- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Focus Partners Wealth Acquires 37,682 Shares of Johnson & Johnson $JNJ
Institutional investor raises stake in pharmaceutical giant by 3%
Mar. 16, 2026 at 10:05am
Got story updates? Submit your updates here. ›
Focus Partners Wealth, an institutional investor, increased its stake in Johnson & Johnson (NYSE:JNJ) by 3.0% during the third quarter, according to a recent SEC filing. The firm now owns 1,294,964 shares of the company's stock, worth approximately $240 million.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. Changes in institutional ownership of the stock can provide insights into market sentiment and investment trends.
The details
According to the 13F filing, Focus Partners Wealth bought an additional 37,682 shares of Johnson & Johnson during the third quarter, bringing its total position to 1,294,964 shares. This represents about 0.05% of the company's outstanding shares. The filing indicates the institutional investor sees value in Johnson & Johnson's diversified business model and growth prospects.
- Focus Partners Wealth filed the 13F report disclosing the increased stake in Johnson & Johnson on March 16, 2026.
The players
Focus Partners Wealth
An institutional investment firm that manages a portfolio of stocks, including a significant position in pharmaceutical giant Johnson & Johnson.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals, medical devices, and consumer health.
The takeaway
The increased stake by Focus Partners Wealth in Johnson & Johnson suggests the institutional investor sees continued growth potential in the diversified healthcare company, despite any near-term market volatility. This is a positive signal for Johnson & Johnson's long-term outlook.
